Results 111 to 120 of about 113,784 (303)

Black hole in Dehnen $$\left( 1,4,\frac{1}{2}\right) $$ 1 , 4 , 1 2 dark matter halo: exact solution, lensing, light ring, and thermodynamics

open access: yesEuropean Physical Journal C: Particles and Fields
In this work, we present the exact solution of a static, spherically symmetric black hole embedded in a Dehnen $$\left( 1,4,\frac{1}{2}\right) $$ 1 , 4 , 1 2 dark matter halo. We explore both its optical and thermodynamic properties.
David Senjaya
doaj   +1 more source

Dark energy and dark matter in galaxy halos

open access: yesPhysics Letters B, 2006
7 pages, 1 figure, references added and discussion ...
openaire   +3 more sources

Ketogenic Diet as an Epigenetic Therapy in SETD1B‐Related Epilepsy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Histone lysine methyltransferases such as SETD1B regulate chromatin structure and gene transcription. Ketone bodies, including butyrate, act as histone deacetylase inhibitors. We report a 4‐year‐old boy with SETD1B‐related absence epilepsy, refractory to conventional medications, who achieved sustained > 90% seizure reduction on the Modified ...
Erica Tsang   +10 more
wiley   +1 more source

Importance of Initial Condition on Bar Secular Evolution: Role of Halo Angular Momentum Distribution Discontinuity

open access: yesThe Astrophysical Journal
The dark matter halo properties, for example, mass, spin, and concentration, play a significant role in the formation and evolution of bars in disk galaxies.
Sandeep Kumar Kataria, Juntai Shen
doaj   +1 more source

Physical properties underlying observed kinematics of satellite galaxies

open access: yes, 2013
We study the kinematics of satellites around isolated galaxies selected from the Sloan Digital Sky Survey (SDSS) spectroscopic catalog. Using a model of the phase-space density previously measured for the halos of LCDM dark matter cosmological ...
Abazajian   +81 more
core   +3 more sources

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro   +6 more
wiley   +1 more source

The outer profile of dark matter halos: an analytical approach

open access: yes, 2016
A steepening feature in the outer density profiles of dark matter halos indicating the splashback radius has drawn much attention recently. Possible observational detections have even been made for galaxy clusters. Theoretically, Adhikari et al.
Shi, Xun
core   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw   +5 more
wiley   +1 more source

On the Mass Dependence of the Inner Slopes of Dark Matter Density Profiles

open access: yesOpen Astronomy, 2014
We study through a semi-analytic model how the inner slopes of relaxed ΛCDM dark matter halos with and without baryons depend on the halo mass. We find that the inner logarithmic density slope, α ≡ d log ρ/d log r, of dark matter halos with baryons has a
Del Popolo A.
doaj   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy